BBI Solutions to Showcase Technologies for Next-Generation Diagnostics
By HospiMedica International staff writers
Posted on 14 Nov 2017
Image: BBI Solutions will showcase its Morffi signal enhancement technology at MEDICA 2017, the world’s largest medical trade fair (Photo courtesy of BBI Solutions).
Immunoassay development and manufacturing specialist BBI Solutions (Cardiff, UK) will showcase its award-winning Morffi signal enhancement technology at the world’s largest medical trade fair, MEDICA 2017, which runs from November 13 to 16 in Dusseldorf, Germany. The Morffi signal enhancement technology is a patent pending conjugate blocking technology that could provide a two-fold enhancement in the limit of detection in both plasma and urine as compared to existing gold conjugation methods; enabling lateral flow immunoassays to compete with traditional lab-based testing platforms.
Additionally, BBI Solutions, along with its sister company, BBI Group’s mobile arm, Novarum (Scotland, UK), will showcase their innovative mobile technology which allows users to read and share results of lateral flow diagnostic tests using just a smartphone. The company’s smartphone readers enable tests to be accurately read from the point of care, at a patient’s home or in remote and challenging environments, with the results shared securely with healthcare professionals or specific end-users.
“This is an incredibly exciting period of growth and innovation for the business. We’re looking forward to the opportunity to outline BBI Solutions’ enhanced capabilities and showcase the potential presented by our landmark Morffi technology,” said Liam Taylor, managing director of BBI Solutions. “The combined impact of BBI Solutions’ and Novarum’s technology offers an outstanding end-to-end solution that has the potential to revolutionize the lateral flow diagnostics landscape and we relish the chance to showcase this compelling proposition during the event.”